FDA NDI Draft Is A Push For Tighter Supplement Regulation – Stakeholders
This article was originally published in The Tan Sheet
Executive Summary
FDA proposed “a pretty crazy” NDI notification draft guidance, says attorney Wes Siegner, because “they think everything is an NDI.” Other stakeholders acknowledge FDA wants tighter regulation of the industry, but say writing and imposing rules for supplement manufacturing is a two-way street.
You may also be interested in...
FDA ‘Struggles’ Against Spiked Supplements, ‘Thorn’ In Industry’s Side
A “continual thorn in the side of responsible” supplement firm is illegally spiked products, industry champion Senator Hatch says. FDA, meanwhile, “struggles to provide effective deterrents” to rid the market of bad actors.
FDA ‘Struggles’ Against Spiked Supplements, ‘Thorn’ In Industry’s Side
A “continual thorn in the side of responsible” supplement firm is illegally spiked products, industry champion Senator Hatch says. FDA, meanwhile, “struggles to provide effective deterrents” to rid the market of bad actors.
Product Registration Regime Chokes China Supplement Industry Growth
The U.S.-China Health Products Association says China is considering reforms to the country’s food product industry regulations. Relaxing the supplement registration requirement would increase demand for Chinese suppliers’ ingredients from firms that would sell more of their finished products in the country.